Clinical trial
Sedating Antidepressant Improves Driving Safety in Patients With Major…
NCT00385437 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00385437 |
|---|---|
| Title | Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder |
| Official title | Antidepressant Response to a Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression, Excessive Daytime Sleepiness |
| Intervention type | Behavioral, Drug |
| Interventions | Driving Simulator Testing, Mirtazapine Treatment |
| Enrollment | 16 |
| Start date | Apr 1, 2003 |
| Completion | Jun 1, 2004 |
| First posted | Oct 9, 2006 |
| Last update posted | Oct 9, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: